Aspirin may fight breast cancer
A low dose of aspirin every day could help keep breast cancer at bay, concludes a new study from the Veterans Affairs Medical Center in Kansas City and the University of Kansas Medical Center, Research presented at the annual meeting of the American Society for Biochemistry and Molecular Biology found that a low, but regular dose of aspirin could help treat and even prevent breast cancer from spreading.
The study examined the effects of aspirin on mice with one of two types of cancer: the aggressive ‘triple-negative’ breast cancer and hormone-receptor positive breast cancer.
The results found that aspirin actually interferes with the stem cells that researchers believe fuel the growth and spread of tumors in triple-negative breast cancer. As a result, the aspirin was able to block the growth of cancer cells in mice models and, in some cases, shrink the tumors.
The researchers also found that aspirin boosted the effects of the cancer-fighting drug tamoxifen, which is used to treat hormone-positive breast cancers.
This new study builds on about 20 years of research on aspirin’s role in preventing and treating all kinds of cancers. Experts, however, pointed out that it’s still very early in this phase of research and that similar results have yet to be shown in human patients.